'In this study, we demonstrated that there are in fact some genes without which a cancer cell cannot survive, making them excellent targets for CRISPR therapy,' said Prof. Dan Peer.
Uri Gruenbaum, CEO and Co-Founder at TipRanks and TAU Alumnus in conversation with Jake Laznik, Senior Breaking News Desk Manager, The Jerusalem Post.
Nimrod Vax, CPO & Co-Founder, BigID, and TAU Alumnus in conversation with Jake Laznik, Senior Breaking News Desk Manager, The Jerusalem Post.
The researchers predicted that the new tool will enable the development of personalized therapeutics by monitoring PTEN activity in various biological settings.
Alon Arvatz, CEO& Co-founder of PointFive, TAU Alumnus of the Faculty of Law, in conversation with Jake Laznik, Senior Breaking News Desk Manager, The Jerusalem Post.
Completely different mechanisms cause damage in males and females with a rare genetic syndrome.
Scholars and experts gather in Florence to address rising antisemitism and strategies for resilience.
Early clinical data paints a striking picture: 20 successful pregnancies from just 31 embryo transfers, a dramatic advantage over the 14 pregnancies from 41 transfers seen in the control group.
To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and delivered it to animal models with Crohn's disease.
WATCH: The groundbreaking discovery of Prof. (Emerita) Illana Gozes.
JPOST Digital Library
